Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Arvids Irmejs; Gunta Purkalne; Marianna Bitina; Andris Gardovskis; Janis Gardovskis

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Arvids Irmejs, Gunta Purkalne, Marianna Bitina, Andris Gardovskis, Janis Gardovskis

Research output: Contribution to journal › Comment/debate

13 Downloads (Pure)

Original language	English
Article number	119
Pages (from-to)	125-126
Number of pages	2
Journal	Hereditary cancer in clinical practice
Volume	5
Issue number	3
Publication status	Published - 15 Sept 2007

Field of Science*

3.2 Clinical medicine
3.1 Basic medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

DiscussionFinal published version, 228 KB

https://hccpjournal.biomedcentral.com/track/pdf/10.1186/1897-4287-5-3-119.pdf

Cite this

@article{277c77358e444583b5beebd9c47ab33f,

title = "Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers",

author = "Arvids Irmejs and Gunta Purkalne and Marianna Bitina and Andris Gardovskis and Janis Gardovskis",

year = "2007",

month = sep,

day = "15",

language = "English",

volume = "5",

pages = "125--126",

journal = "Hereditary cancer in clinical practice",

issn = "1731-2302",

publisher = "BioMed Central Ltd.",

number = "3",

}

TY - JOUR

T1 - Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

AU - Irmejs, Arvids

AU - Purkalne, Gunta

AU - Bitina, Marianna

AU - Gardovskis, Andris

AU - Gardovskis, Janis

PY - 2007/9/15

Y1 - 2007/9/15

UR - https://www.scopus.com/pages/publications/35348883267

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736985/

M3 - Comment/debate

AN - SCOPUS:35348883267

SN - 1731-2302

VL - 5

SP - 125

EP - 126

JO - Hereditary cancer in clinical practice

JF - Hereditary cancer in clinical practice

IS - 3

M1 - 119

ER -

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Cite this